EP1372553A4 - Hydrogele, die als reaktion auf veränderungen in der umgebung einer volumetrischen expansion unterzogen werden und ihre herstellungs- und verwendungsmethoden - Google Patents

Hydrogele, die als reaktion auf veränderungen in der umgebung einer volumetrischen expansion unterzogen werden und ihre herstellungs- und verwendungsmethoden

Info

Publication number
EP1372553A4
EP1372553A4 EP02750563A EP02750563A EP1372553A4 EP 1372553 A4 EP1372553 A4 EP 1372553A4 EP 02750563 A EP02750563 A EP 02750563A EP 02750563 A EP02750563 A EP 02750563A EP 1372553 A4 EP1372553 A4 EP 1372553A4
Authority
EP
European Patent Office
Prior art keywords
hydrogels
manufacture
environment
response
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP02750563A
Other languages
English (en)
French (fr)
Other versions
EP1372553B1 (de
EP1372553A1 (de
Inventor
Gregory M Cruise
Michael J Constant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MicroVention Inc
Original Assignee
MicroVention Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MicroVention Inc filed Critical MicroVention Inc
Priority to EP10188630A priority Critical patent/EP2308431B1/de
Priority to EP10188595.2A priority patent/EP2363104B1/de
Publication of EP1372553A1 publication Critical patent/EP1372553A1/de
Publication of EP1372553A4 publication Critical patent/EP1372553A4/de
Application granted granted Critical
Publication of EP1372553B1 publication Critical patent/EP1372553B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F22/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F22/36—Amides or imides
    • C08F22/38—Amides
    • C08F22/385—Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Medicinal Preparation (AREA)
EP02750563.5A 2001-03-13 2002-02-28 Hydrogele, die als reaktion auf veränderungen in der umgebung einer volumetrischen expansion unterzogen werden und ihre herstellungs- und verwendungsmethoden Expired - Lifetime EP1372553B1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP10188630A EP2308431B1 (de) 2001-03-13 2002-02-28 Hydrogel, das sich mit Änderungen der Umweltbedingungen ausdehnt, Herstellungsmethoden und Verwendungen für das Hydrogel.
EP10188595.2A EP2363104B1 (de) 2001-03-13 2002-02-28 Hydrogele, die auf Änderungen in ihrer Umgebung mit einer Volumenexpansion reagieren, ihre Herstellung und Verwendung

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/804,935 US6878384B2 (en) 2001-03-13 2001-03-13 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
US804935 2001-03-13
PCT/US2002/005988 WO2002071994A1 (en) 2001-03-13 2002-02-28 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP10188595.2A Division-Into EP2363104B1 (de) 2001-03-13 2002-02-28 Hydrogele, die auf Änderungen in ihrer Umgebung mit einer Volumenexpansion reagieren, ihre Herstellung und Verwendung
EP10188630A Division-Into EP2308431B1 (de) 2001-03-13 2002-02-28 Hydrogel, das sich mit Änderungen der Umweltbedingungen ausdehnt, Herstellungsmethoden und Verwendungen für das Hydrogel.

Publications (3)

Publication Number Publication Date
EP1372553A1 EP1372553A1 (de) 2004-01-02
EP1372553A4 true EP1372553A4 (de) 2006-04-12
EP1372553B1 EP1372553B1 (de) 2014-06-25

Family

ID=25190260

Family Applications (3)

Application Number Title Priority Date Filing Date
EP10188630A Expired - Lifetime EP2308431B1 (de) 2001-03-13 2002-02-28 Hydrogel, das sich mit Änderungen der Umweltbedingungen ausdehnt, Herstellungsmethoden und Verwendungen für das Hydrogel.
EP10188595.2A Expired - Lifetime EP2363104B1 (de) 2001-03-13 2002-02-28 Hydrogele, die auf Änderungen in ihrer Umgebung mit einer Volumenexpansion reagieren, ihre Herstellung und Verwendung
EP02750563.5A Expired - Lifetime EP1372553B1 (de) 2001-03-13 2002-02-28 Hydrogele, die als reaktion auf veränderungen in der umgebung einer volumetrischen expansion unterzogen werden und ihre herstellungs- und verwendungsmethoden

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP10188630A Expired - Lifetime EP2308431B1 (de) 2001-03-13 2002-02-28 Hydrogel, das sich mit Änderungen der Umweltbedingungen ausdehnt, Herstellungsmethoden und Verwendungen für das Hydrogel.
EP10188595.2A Expired - Lifetime EP2363104B1 (de) 2001-03-13 2002-02-28 Hydrogele, die auf Änderungen in ihrer Umgebung mit einer Volumenexpansion reagieren, ihre Herstellung und Verwendung

Country Status (9)

Country Link
US (5) US6878384B2 (de)
EP (3) EP2308431B1 (de)
JP (2) JP4416151B2 (de)
CN (2) CN1306916C (de)
AU (3) AU2002306605B2 (de)
BR (1) BRPI0208034B8 (de)
CA (1) CA2439925C (de)
ES (3) ES2408014T3 (de)
WO (1) WO2002071994A1 (de)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014200734B2 (en) * 2001-03-13 2015-11-05 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
AU2002305401A1 (en) * 2001-05-04 2002-11-18 Concentric Medical Hydrogel filament vaso-occlusive device
AU2002345795B2 (en) * 2001-06-20 2008-01-10 Microvention, Inc. Medical devices having full or partial polymer coatings and their methods of manufacture
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8252040B2 (en) * 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
MXPA04007428A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US7551749B2 (en) 2002-08-23 2009-06-23 Bose Corporation Baffle vibration reducing
DE10330269A1 (de) * 2003-07-04 2005-01-27 Instraction Gmbh System umfassend Effektoren und volumenveränderbare Rezeptoren-modifizierte Elastomere, Verfahren zu ihrer Herstellung und ihrer Verwendung
JP2007509716A (ja) * 2003-10-29 2007-04-19 ジェンティス インコーポレイテッド 組織工学用の重合可能なエマルション
CA2558623C (en) * 2004-02-06 2013-04-16 Georgia Tech Research Corporation Surface directed cellular attachment
CA2558661C (en) 2004-02-06 2012-09-04 Georgia Tech Research Corporation Load bearing biocompatible device
CA2758946C (en) 2004-05-25 2014-10-21 Tyco Healthcare Group Lp Vascular stenting for aneurysms
US9675476B2 (en) 2004-05-25 2017-06-13 Covidien Lp Vascular stenting for aneurysms
CA2565106C (en) 2004-05-25 2013-11-05 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
WO2006028370A1 (en) * 2004-09-10 2006-03-16 Stichting Dutch Polymer Institute Radiopaque prosthetic intervertebral disc nucleus
US7201918B2 (en) * 2004-11-16 2007-04-10 Microvention, Inc. Compositions, systems and methods for treatment of defects in blood vessels
US7419486B2 (en) * 2005-06-15 2008-09-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Treatment and diagnostic catheters with hydrogel electrodes
GB0523999D0 (en) * 2005-11-25 2006-01-04 Univ Manchester Microgel particle
US7959676B2 (en) * 2006-02-13 2011-06-14 Lanx, Inc. Method and apparatus for intervertebral disc support and repair
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
JP2010500917A (ja) 2006-06-15 2010-01-14 マイクロベンション， インコーポレイテッド 膨張性ポリマーで構成される塞栓形成デバイス
US8771713B2 (en) 2007-03-12 2014-07-08 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US8821899B2 (en) 2007-03-12 2014-09-02 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US8741316B2 (en) * 2007-03-12 2014-06-03 Board Of Regents, The University Of Texas System Highly porous, recognitive polymer systems
US9155703B2 (en) 2007-03-12 2015-10-13 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
WO2008151204A1 (en) * 2007-06-04 2008-12-11 Sequent Medical Inc. Methods and devices for treatment of vascular defects
EP2162101B1 (de) 2007-06-25 2019-02-20 MicroVention, Inc. Selbstexpandierende prothese
BRPI0821070B1 (pt) * 2007-12-21 2018-10-23 Microvention Inc dispositivo para implantação e método para a preparação de um filamento de hidrogel para implantação em um animal
WO2009108760A2 (en) * 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
EP2265193B1 (de) 2008-04-21 2011-11-16 NFocus Neuromedical, Inc. Kugelgeflecht-embolievorrichtung und -ausgabesysteme
JP2011519632A (ja) * 2008-05-02 2011-07-14 シークエント メディカル， インコーポレイテッド 血管障害の治療のためのフィラメントデバイス
WO2009140437A1 (en) 2008-05-13 2009-11-19 Nfocus Neuromedical, Inc. Braid implant delivery systems
US8180076B2 (en) * 2008-07-31 2012-05-15 Bose Corporation System and method for reducing baffle vibration
EP2172236A1 (de) * 2008-10-03 2010-04-07 Koninklijke Philips Electronics N.V. Brustpumpsystem
JP2010162063A (ja) * 2009-01-13 2010-07-29 Japan Health Science Foundation 塞栓材
JP2012100680A (ja) * 2009-03-04 2012-05-31 Terumo Corp 血管内用処置材
JP2010227172A (ja) * 2009-03-26 2010-10-14 Terumo Corp 軟組織増大材料
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
US8409269B2 (en) 2009-12-21 2013-04-02 Covidien Lp Procedures for vascular occlusion
JP2013505791A (ja) * 2009-09-24 2013-02-21 マイクロベンション インコーポレイテッド 医学的使用のための注射用ヒドロゲル繊維
JP5401254B2 (ja) * 2009-10-13 2014-01-29 昌典 石原 多孔質合成樹脂製造方法および同多孔質合成樹脂製造方法により製造された多孔質合成樹脂材
US9993252B2 (en) 2009-10-26 2018-06-12 Microvention, Inc. Embolization device constructed from expansile polymer
AU2010315106A1 (en) * 2009-11-05 2012-05-17 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
US8337448B2 (en) 2010-01-29 2012-12-25 Baxter International Inc. Apparatus for monitoring and controlling peritoneal dialysis
EP2613735B1 (de) 2010-09-10 2018-05-09 Covidien LP Vorrichtungen zur behandlung von gefässdefekten
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
WO2012078678A1 (en) 2010-12-06 2012-06-14 Tyco Healthcare Group Lp Vascular remodeling device
US20120245674A1 (en) 2011-03-25 2012-09-27 Tyco Healthcare Group Lp Vascular remodeling device
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
CA2835427A1 (en) 2011-05-11 2012-11-15 Microvention, Inc. Device for occluding a lumen
CN103547222B (zh) 2011-05-11 2016-02-10 柯惠有限合伙公司 脉管重塑装置
US9155543B2 (en) 2011-05-26 2015-10-13 Cartiva, Inc. Tapered joint implant and related tools
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US9072620B2 (en) 2011-11-04 2015-07-07 Covidien Lp Protuberant aneurysm bridging device deployment method
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
EP2919668A2 (de) 2012-11-13 2015-09-23 Covidien LP Verschlussvorrichtungen
WO2014164357A1 (en) 2013-03-11 2014-10-09 Microvention, Inc. Implantable device with adhesive properties
CN105142543B (zh) 2013-03-15 2019-06-04 柯惠有限合伙公司 血管植入物的输送与分离机构
US10736758B2 (en) 2013-03-15 2020-08-11 Covidien Occlusive device
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9963556B2 (en) 2013-09-18 2018-05-08 Senseonics, Incorporated Critical point drying of hydrogels in analyte sensors
JP6641265B2 (ja) * 2013-09-19 2020-02-05 マイクロベンション インコーポレイテッドＭｉｃｒｏｖｅｎｔｉｏｎ， Ｉｎｃ． ポリマーフィルム
JP6405369B2 (ja) * 2013-09-19 2018-10-17 テルモ株式会社 ポリマー粒子
CN105916495B (zh) 2013-11-08 2019-11-12 泰尔茂株式会社 聚合物颗粒
US9795400B2 (en) 2013-11-13 2017-10-24 Covidien Lp Galvanically assisted attachment of medical devices to thrombus
JP6456969B2 (ja) * 2014-02-21 2019-01-23 マサチューセッツ インスティテュート オブ テクノロジー 膨張顕微鏡法
EP3113722A4 (de) * 2014-03-07 2017-12-06 Endologix, Inc. Herstellung von hydrogelen und materialien dafür
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
WO2015167752A1 (en) * 2014-04-29 2015-11-05 Microvention, Inc. Polymers including active agents
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US10959865B2 (en) 2014-05-12 2021-03-30 Jeffrey E. Thomas Photo-activatable gel coated intracranial stent and embolic coil
IL282559B (en) 2014-07-17 2022-07-01 Univ California Self-reinforced and controllable microgel particles for biomedical applications
US9814466B2 (en) 2014-08-08 2017-11-14 Covidien Lp Electrolytic and mechanical detachment for implant delivery systems
TW201625754A (zh) * 2014-11-21 2016-07-16 艾倫塔斯有限公司 單一成份、儲存穩定、可硬化之聚矽氧組成物
WO2016154592A1 (en) * 2015-03-26 2016-09-29 Microvention, Inc. Embiolic particles
CA2981061A1 (en) 2015-03-31 2016-10-06 Cartiva, Inc. Hydrogel implants with porous materials and methods
AU2016243660B2 (en) 2015-03-31 2020-11-12 Cartiva, Inc. Carpometacarpal (CMC) implants and methods
US10526649B2 (en) 2015-04-14 2020-01-07 Massachusetts Institute Of Technology Augmenting in situ nucleic acid sequencing of expanded biological samples with in vitro sequence information
US11408890B2 (en) 2015-04-14 2022-08-09 Massachusetts Institute Of Technology Iterative expansion microscopy
US10059990B2 (en) 2015-04-14 2018-08-28 Massachusetts Institute Of Technology In situ nucleic acid sequencing of expanded biological samples
CA2981074C (en) 2015-04-14 2023-03-28 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
WO2017023903A1 (en) * 2015-08-03 2017-02-09 President And Fellows Of Harvard College Phase-transforming and switchable metamaterials
WO2017027368A1 (en) 2015-08-07 2017-02-16 Massachusetts Institute Of Technology Protein retention expansion microscopy
EP3332029B1 (de) 2015-08-07 2021-10-06 Massachusetts Institute of Technology Nanoskalige bildgebung von proteinen und nukleinsäuren durch expansionsmikroskopie
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US10314593B2 (en) 2015-09-23 2019-06-11 Covidien Lp Occlusive devices
CA3004745A1 (en) 2015-11-12 2017-05-18 University Of Virginia Patent Foundation Compositions and methods for vas-occlusive contraception and reversal thereof
WO2017142879A1 (en) 2016-02-16 2017-08-24 The Regents Of The University Of California Methods for immune system modulation with microporous annealed particle gels
WO2017165833A1 (en) 2016-03-24 2017-09-28 Covidien Lp Thin wall constructions for vascular flow diversion
US10828037B2 (en) 2016-06-27 2020-11-10 Covidien Lp Electrolytic detachment with fluid electrical connection
US10828039B2 (en) 2016-06-27 2020-11-10 Covidien Lp Electrolytic detachment for implantable devices
US11051822B2 (en) 2016-06-28 2021-07-06 Covidien Lp Implant detachment with thermal activation
US20180028715A1 (en) 2016-07-27 2018-02-01 Contraline, Inc. Carbon-based compositions useful for occlusive medical devices and methods of making and using them
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
EP4279139A3 (de) 2016-09-28 2024-01-24 Terumo Corporation Polymerpartikel
US20180206851A1 (en) * 2016-10-19 2018-07-26 Daniel E. Walzman Hydrogel intrasaccular occlusion device
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
AU2017394923B2 (en) 2016-12-29 2022-07-14 Tempo Therapeutics, Inc. Methods and systems for treating a site of a medical implant
US11931928B2 (en) * 2016-12-29 2024-03-19 Evonik Superabsorber Llc Continuous strand superabsorbent polymerization
US10995361B2 (en) 2017-01-23 2021-05-04 Massachusetts Institute Of Technology Multiplexed signal amplified FISH via splinted ligation amplification and sequencing
US11385481B1 (en) 2017-02-01 2022-07-12 Ram Pattikonda Advanced dynamic focus eyewear
WO2018157048A1 (en) 2017-02-24 2018-08-30 Massachusetts Institute Of Technology Methods for examining podocyte foot processes in human renal samples using conventional optical microscopy
CA3058726A1 (en) * 2017-04-05 2018-10-11 Setbone Medical Ltd. Property changing implant
CN107158560A (zh) * 2017-04-27 2017-09-15 清华大学 基于水凝胶溶胀特性的可控自变形神经微电极
WO2019023214A1 (en) 2017-07-25 2019-01-31 Massachusetts Institute Of Technology ATAC IN SITU SEQUENCING
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
WO2019082991A1 (ja) * 2017-10-25 2019-05-02 メディギア・インターナショナル株式会社 生体分解性及び生体代謝性の腫瘍封止剤
US11873374B2 (en) 2018-02-06 2024-01-16 Massachusetts Institute Of Technology Swellable and structurally homogenous hydrogels and methods of use thereof
US11065009B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US11065136B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US10905432B2 (en) 2018-08-22 2021-02-02 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US10912569B2 (en) 2018-08-22 2021-02-09 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
CN111388044A (zh) 2018-12-17 2020-07-10 柯惠有限合伙公司 闭塞装置
CN111393563B (zh) * 2019-01-02 2023-04-07 湖南工业大学 一种温敏性水凝胶的制备方法及监测模具
CN111686310B (zh) * 2019-03-11 2022-03-29 国家纳米科学中心 一种抗菌导尿管及其制备方法和应用
CN113573650B (zh) 2019-03-15 2024-05-28 后续医疗股份有限公司 用于治疗血管缺陷的具有柔性连接部的丝装置
US11559309B2 (en) 2019-03-15 2023-01-24 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
CN113573765A (zh) 2019-03-15 2021-10-29 后续医疗股份有限公司 用于治疗血管缺陷的丝装置
US11717924B2 (en) 2019-11-04 2023-08-08 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
WO2021113505A1 (en) 2019-12-05 2021-06-10 Massachusetts Institute Of Technology Method for preparing a specimen for expansion microscopy
CN111333866B (zh) * 2020-03-20 2023-03-24 浙江理工大学 一种单层水凝胶、制备方法及用作柔性抓手的应用
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
CN112300413B (zh) * 2020-12-29 2021-04-09 北京泰杰伟业科技有限公司 一种超细均匀的丙烯酰胺类聚合物水凝胶丝的制备方法及应用
CN114561237B (zh) * 2022-04-19 2022-10-28 中国科学院兰州化学物理研究所 一种剪切响应性水基凝胶润滑剂的制备方法
CN115746360B (zh) * 2022-11-24 2023-12-12 无锡学院 一种间隙可调的柔性表面增强拉曼散射基底及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004732A1 (en) * 1989-10-03 1991-04-18 Advanced Polymer Systems, Inc. Erodible macroporous hydrogel particles and preparation thereof
US5415864A (en) * 1990-04-18 1995-05-16 University Of Utah Research Foundation Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting PH-dependent swelling
US5447727A (en) * 1992-10-14 1995-09-05 The Dow Chemical Company Water-absorbent polymer having improved properties
US5863551A (en) * 1996-10-16 1999-01-26 Organogel Canada Ltee Implantable polymer hydrogel for therapeutic uses
EP1024176A1 (de) * 1998-08-13 2000-08-02 Nippon Shokubai Co., Ltd. Wasserquellbare vernetzte polymerzusammensetzung und verfahren zu deren herstellung

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005161A (en) 1986-01-28 1999-12-21 Thm Biomedical, Inc. Method and device for reconstruction of articular cartilage
US4990138A (en) * 1989-07-18 1991-02-05 Baxter International Inc. Catheter apparatus, and compositions useful for producing same
US5635482A (en) 1989-08-14 1997-06-03 The Regents Of The University Of California Synthetic compounds and compositions with enhanced cell binding
US5226902A (en) 1991-07-30 1993-07-13 University Of Utah Pulsatile drug delivery device using stimuli sensitive hydrogel
US5514379A (en) 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US5554147A (en) 1994-02-01 1996-09-10 Caphco, Inc. Compositions and devices for controlled release of active ingredients
US5651979A (en) 1995-03-30 1997-07-29 Gel Sciences, Inc. Apparatus and method for delivering a biologically active compound into a biological environment
US5750585A (en) 1995-04-04 1998-05-12 Purdue Research Foundation Super absorbent hydrogel foams
DE69623597T2 (de) 1995-12-19 2003-05-22 Bracco Research Sa Tricodobenzene-polymere enthaltende zusammensetzungen zur abbildung des gastrointestinaltraktes
PL335974A1 (en) 1997-04-02 2000-06-05 Purdue Research Foundation Method of orally administering proteins
US6224893B1 (en) * 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US5891192A (en) 1997-05-22 1999-04-06 The Regents Of The University Of California Ion-implanted protein-coated intralumenal implants
US6077880A (en) * 1997-08-08 2000-06-20 Cordis Corporation Highly radiopaque polyolefins and method for making the same
DE69922352T2 (de) * 1998-03-06 2005-12-15 Biosphere Medical, Inc., Rockland Implantierbare partikel zur erhöhung des gewebevolumens und zur behandlung von gastroösophagalreflux, inkontinenz und hautfalten
US6165193A (en) * 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
KR20000012970A (ko) 1998-08-03 2000-03-06 김효근 썰폰아마이드기를 포함하는 ph 민감성 고분자 및 그의 제조방법
US5952232A (en) 1998-09-17 1999-09-14 Rothman; James Edward Expandible microparticle intracellular delivery system
US6187024B1 (en) 1998-11-10 2001-02-13 Target Therapeutics, Inc. Bioactive coating for vaso-occlusive devices
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
US6371904B1 (en) * 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
EP1031354A3 (de) 1999-01-19 2003-02-05 Rohm And Haas Company Polymere MRI Kontrastmittel
US6663607B2 (en) 1999-07-12 2003-12-16 Scimed Life Systems, Inc. Bioactive aneurysm closure device assembly and kit
US7291673B2 (en) 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6506408B1 (en) * 2000-07-13 2003-01-14 Scimed Life Systems, Inc. Implantable or insertable therapeutic agent delivery device
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
EP2319430B1 (de) 2001-05-29 2013-11-13 Microvention, Inc. Gerät zur vaskularen Embolisation und Verfahren zu dessen Herstellung
US20030014075A1 (en) * 2001-07-16 2003-01-16 Microvention, Inc. Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation
US20030134032A1 (en) 2001-11-16 2003-07-17 Hassan Chaouk Methods for initiating in situ formation of hydrogels
WO2003089506A1 (en) 2002-04-22 2003-10-30 Purdue Research Foundation Hydrogels having enhanced elasticity and mechanical strength properties
EP1526815A1 (de) 2002-07-31 2005-05-04 MicroVention, Inc. Aus drei koaxiale elemente bestehende vaso-okklusionsvorrichtung
US20050119687A1 (en) 2003-09-08 2005-06-02 Dacey Ralph G.Jr. Methods of, and materials for, treating vascular defects with magnetically controllable hydrogels
JP2010500917A (ja) 2006-06-15 2010-01-14 マイクロベンション， インコーポレイテッド 膨張性ポリマーで構成される塞栓形成デバイス

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004732A1 (en) * 1989-10-03 1991-04-18 Advanced Polymer Systems, Inc. Erodible macroporous hydrogel particles and preparation thereof
US5415864A (en) * 1990-04-18 1995-05-16 University Of Utah Research Foundation Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting PH-dependent swelling
US5447727A (en) * 1992-10-14 1995-09-05 The Dow Chemical Company Water-absorbent polymer having improved properties
US5863551A (en) * 1996-10-16 1999-01-26 Organogel Canada Ltee Implantable polymer hydrogel for therapeutic uses
EP1024176A1 (de) * 1998-08-13 2000-08-02 Nippon Shokubai Co., Ltd. Wasserquellbare vernetzte polymerzusammensetzung und verfahren zu deren herstellung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO02071994A1 *

Also Published As

Publication number Publication date
US8465779B2 (en) 2013-06-18
US8231890B2 (en) 2012-07-31
EP1372553B1 (de) 2014-06-25
US20020176880A1 (en) 2002-11-28
ES2390605T3 (es) 2012-11-14
CA2439925A1 (en) 2002-09-19
US6878384B2 (en) 2005-04-12
ES2408014T3 (es) 2013-06-17
CN1306916C (zh) 2007-03-28
AU2007216682A1 (en) 2007-09-27
EP2308431A1 (de) 2011-04-13
WO2002071994A1 (en) 2002-09-19
BRPI0208034B1 (pt) 2018-02-06
EP2363104B1 (de) 2013-04-24
JP4416151B2 (ja) 2010-02-17
CN1617694A (zh) 2005-05-18
US20050196426A1 (en) 2005-09-08
US20120302654A1 (en) 2012-11-29
CN101024729A (zh) 2007-08-29
ES2478992T3 (es) 2014-07-23
EP1372553A1 (de) 2004-01-02
BR0208034A (pt) 2004-02-25
BRPI0208034B8 (pt) 2021-07-27
US8734834B2 (en) 2014-05-27
JP2004528880A (ja) 2004-09-24
JP2010022847A (ja) 2010-02-04
US20130274362A1 (en) 2013-10-17
EP2363104A1 (de) 2011-09-07
AU2009213041A1 (en) 2009-10-08
JP5154529B2 (ja) 2013-02-27
EP2308431B1 (de) 2012-07-04
AU2007216682B2 (en) 2009-10-01
AU2002306605B2 (en) 2007-06-14
US20140256837A1 (en) 2014-09-11
CA2439925C (en) 2014-01-14

Similar Documents

Publication Publication Date Title
EP1372553A4 (de) Hydrogele, die als reaktion auf veränderungen in der umgebung einer volumetrischen expansion unterzogen werden und ihre herstellungs- und verwendungsmethoden
GB0515801D0 (en) Time in databases and applications of databases
AU2002350289A1 (en) Polysaccharide biomaterials and methods of use thereof
ZA200305825B (en) Modified antibodies and methods of use
AU2002310268A1 (en) Synchronization of multiple simulation domains in an eda simulation environment
AU2002306768A1 (en) Expression profiles and methods of use
IL158499A (en) Malononitrile compounds and their use in the manufacture of pesticide compositions
AU2002351239A8 (en) Antibody to latent membrane proteins and uses thereof
IL164181A0 (en) Anti-il-tif antibodies and methods of using in inflammation
GB0128361D0 (en) Improvements in and relating to instruments
EP1476150A4 (de) Carboxyfullerene und verwendungsverfahren dafür
EP1419263A4 (de) Hefe-expressionssystem, verfahren zur herstellung von polypeptiden in hefe sowie damit in verbindung stehende zusammensetzungen
AU2003247351A1 (en) Anti-acne compositions and methods of use
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2003214148A8 (en) Use of context identifiers in cache memory
AU2002314887A1 (en) Gads as modifiers of the p53 pathway and methods of use
EP1649037A4 (de) Immobilisierung von oligonukleotiden und proteinen in zuckerhaltigen hydrogelen
GB0222328D0 (en) Improvements in and relating to the control of instruments
AU2003286600A8 (en) Prkcb1 as modifier of branching morphogenesis and methods of use
AU2003276844A8 (en) Formulations of modified antibodies and methods of making the same
EP1633850A4 (de) Ovr115-antikörperzusammensetzung und verwendungsverfahren
AU2002352696A8 (en) Cell substrates and methods of use thereof
GB0313617D0 (en) Transparent conducting structures and methods of production
GB0105273D0 (en) Improvements in or relating to assessment of fertility
EP1414427A4 (de) Kavalacton-zusammensetzungen und anwendungsverfahren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030910

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20060301

17Q First examination report despatched

Effective date: 20081024

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MICROVENTION, INC.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20140107

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 674124

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140715

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2478992

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20140723

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 60246385

Country of ref document: DE

Effective date: 20140807

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140625

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140625

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140926

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 674124

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140625

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20140625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141027

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140625

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140625

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 60246385

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140625

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20150326

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150228

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150228

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150228

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140625

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150228

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20170221

Year of fee payment: 16

Ref country code: ES

Payment date: 20170110

Year of fee payment: 16

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140625

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180228

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20190801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180301

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20210113

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20210216

Year of fee payment: 20

Ref country code: GB

Payment date: 20210217

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60246385

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20220227

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20220227